Immunotherapy for neurological diseases-Reference-Cited by-同舟云学术

Immunotherapy for neurological diseases

Published:2008-09 Issue:3 Volume:128 Page:294-305
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Villoslada Pablo,Moreno Beatriz,Melero Ignacio,Pablos Jose L.,Martino Gianvito,Uccelli Antonio,Montalban Xavier,Avila Jesus,Rivest Serge,Acarin Laia,Appel Stanley,Khoury Samia J.,McGeer Patrick,Ferrer Isidro,Delgado Mario,Obeso Jose,Schwartz Michal

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Immunostimulatory monoclonal antibodies for cancer therapy;Melero;Nat. Rev., Cancer,2007

2. Tumor-driven evolution of immunosuppressive networks during malignant progression;Kim;Cancer Res.,2006

3. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412;Suntharalingam;N. Engl. J. Med.,2006

4. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis;Sun;J. Immunol.,2002

5. Therapeutic strategies for rheumatoid arthritis;Smolen;Nat. Rev. Drug Discov.,2003

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity;Clinical Immunology;2024-10

2. Natural product/diet-based regulation of macrophage polarization: Implications in treatment of inflammatory-related diseases and cancer;The Journal of Nutritional Biochemistry;2024-08

3. Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs;ACS Pharmacology & Translational Science;2024-03-21

4. Large- and Small-Animal Studies of Safety, Pharmacokinetics (PK), and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs;2024-02-09

5. A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments;Biomedicines;2023-09-08